123 related articles for article (PubMed ID: 6430362)
1. The pharmacokinetics of intramuscular gold sodium thiomalate in normal volunteers.
Massarella JW; Waller ES; Crout JE; Yakatan GJ
Biopharm Drug Dispos; 1984; 5(2):101-7. PubMed ID: 6430362
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of gold sodium thiomalate.
Waller ES; Massarella JW; Crout JE; Yakatan GJ
Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):33-47. PubMed ID: 6812186
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of gold sodium thiomalate in rabbits.
Melethil S; Schoepp D
Pharm Res; 1987 Aug; 4(4):332-6. PubMed ID: 3150043
[TBL] [Abstract][Full Text] [Related]
4. Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.
Jellum E; Munthe E; Guldal G; Aaseth J
Ann Rheum Dis; 1980 Apr; 39(2):155-8. PubMed ID: 6770766
[TBL] [Abstract][Full Text] [Related]
5. Intestinal resorption of gold salts used for treatment of rheumatoid arthritis.
Sairanen E; Vähätalo S
Scand J Rheumatol; 1973; 2(2):61-4. PubMed ID: 4201507
[No Abstract] [Full Text] [Related]
6. Clinical pharmacokinetics of oral and injectable gold compounds.
Blocka KL; Paulus HE; Furst DE
Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
[TBL] [Abstract][Full Text] [Related]
7. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
Jellum E; Munthe E; Guldal G; Aaseth J
Scand J Rheumatol Suppl; 1979; (28):28-36. PubMed ID: 109914
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of parenteral and oral gold compounds.
Gottlieb NL
J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
[TBL] [Abstract][Full Text] [Related]
9. Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis.
Jellum E; Munthe E
Ann Rheum Dis; 1982 Aug; 41(4):431-2. PubMed ID: 6810769
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).
Furst DE; Dromgoole SH
Clin Rheumatol; 1984 Mar; 3 Suppl 1():17-24. PubMed ID: 6432409
[TBL] [Abstract][Full Text] [Related]
11. Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate.
Palmer DG; Dunckley JV
Aust N Z J Med; 1973 Oct; 3(5):461-6. PubMed ID: 4204711
[No Abstract] [Full Text] [Related]
12. Metabolism and distribution of gold compounds.
Gottlieb NL
J Rheumatol Suppl; 1979; 5():2-6. PubMed ID: 114646
[TBL] [Abstract][Full Text] [Related]
13. A comparison of tissue gold levels in guinea-pigs after treatment with myocrisin injected intramuscularly and triethylphosphine gold chloride and myocrisin administered orally.
Kamel H; Brown DH; Ottaway JM; Smith WE; Cottney J; Lewis AJ
Agents Actions; 1978 Oct; 8(5):546-50. PubMed ID: 102133
[TBL] [Abstract][Full Text] [Related]
14. Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
Blocka K
Am J Med; 1983 Dec; 75(6A):114-22. PubMed ID: 6419592
[TBL] [Abstract][Full Text] [Related]
15. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
[No Abstract] [Full Text] [Related]
16. Gold disposition in the rat: studies of its plasma half-life and its urinary, biliary and fecal elimination pathways.
Massarella JW; Pearlman RS
J Pharmacol Exp Ther; 1987 Oct; 243(1):247-57. PubMed ID: 3118007
[TBL] [Abstract][Full Text] [Related]
17. The half-life of gold sodium thiomalate.
Waller ES; Massarella JW; Crout JE; Yakatan GJ
Arthritis Rheum; 1979 Dec; 22(12):1418-9. PubMed ID: 117814
[No Abstract] [Full Text] [Related]
18. Acquired epidermolysis bullosa treated with a gold compound.
Livden JK; Nilsen R
Acta Derm Venereol; 1979; 59(4):378-9. PubMed ID: 92161
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of gold in the rat following a single administration of sodium aurothiomalate: mathematical analysis of serum and organ concentrations.
Mason R; Kingsford M
Biochem Pharmacol; 1979 Dec; 28(24):3637-41. PubMed ID: 119544
[No Abstract] [Full Text] [Related]
20. Kinetics of aurothiomalate in serum and synovial fluid.
Gerber RC; Paulus HE; Bluestone R; Lederer M
Arthritis Rheum; 1972; 15(6):625-9. PubMed ID: 4628732
[No Abstract] [Full Text] [Related]
[Next] [New Search]
